Benzodiazepine addiction treatment at Kolmac: Safe, medically supervised outpatient recovery

Every year, thousands of Americans struggle with benzodiazepine dependence, often alongside other substances. In fact, according to the National Institute on Drug Abuse, 14% of opioid overdose deaths also involved benzodiazepines.

These statistics highlight the dire risks of substance use disorder.

At Kolmac Integrated Behavioral Health, our team of dedicated clinicians provides safe, evidence-based outpatient treatment designed for real recovery. We deliver hope, healing, and measurable results for individuals and families affected by benzodiazepine addiction.

What is benzodiazepine dependence?

Benzodiazepine dependence is a medical condition, not a moral failing.

Benzodiazepines (often called “benzos”) are a class of prescription medications commonly used to treat anxiety, insomnia, and seizures.

Familiar names include:

  • Alprazolam (Xanax®)
  • Clonazepam (Klonopin®)
  • Diazepam (Valium®)
  • Lorazepam (Ativan®)

When taken as prescribed, these medications can be safe and effective. However, prolonged use, even as directed, can lead to physical dependence. This means your body adapts to the presence of the drug, and stopping suddenly can cause withdrawal.

The Food and Drug Administration has required boxed warnings on all benzodiazepines to raise awareness about the risks of dependence, withdrawal, and misuse, even when used as prescribed.

If you’re struggling to stop or worried about your use, know that you are not alone. Dependence is a medical issue, and seeking help is a sign of strength, not shame.

Why benzo withdrawal requires medical supervision

Benzodiazepine withdrawal is not only uncomfortable; it can also be dangerous without medical support. Symptoms may range from anxiety, insomnia, and tremors to life-threatening complications such as seizures.

The course of withdrawal is highly unpredictable and can vary dramatically from person to person, depending on factors like dosage, duration of use, and co-occurring medical conditions. According to recent research published by the National Institute of Health, the severity and timeline of symptoms can be difficult to anticipate. This makes self-detox unsafe for many individuals.

At Kolmac, our expert clinicians take these risks seriously. We never recommend stopping benzodiazepines suddenly or alone. With medical supervision, withdrawal can be managed safely and comfortably, reducing the risk of complications and supporting long-term recovery.

How Kolmac treats benzodiazepine addiction

Kolmac pioneered the nation’s first intensive outpatient program (IOP) addiction treatment approach. With more than 50,000 patients served since 1973, our model has offered a treatment framework that has helped diverse people manage substance use disorders with compassion, medical expertise, and real-world outcomes.

Virtual detox and medical supervision

We offer virtual detox, allowing you to begin withdrawal safely from the comfort of your home while maintaining close contact with our medical team.

Our clinicians conduct thorough assessments and tailor your detox plan to your unique needs. You will participate in daily virtual check-ins, and we provide 24/7 access to medical support throughout the acute withdrawal phase.

Medication-Assisted Treatment (MAT)

Although there is no FDA-approved Medication-Assisted Treatment (MAT) specifically for benzodiazepine use disorder, our team may use supportive medications to ease withdrawal symptoms, manage anxiety, and stabilize your health during detox.

Your personalized plan may include non-addictive medications, careful tapering, and ongoing symptom monitoring. All of this is delivered by experienced addiction clinicians.

IOP after detox stabilization

Once you are medically stable, you will transition into our substance use IOP. Our evidence-based program is designed to address both substance use and underlying mental health concerns.

IOP includes group therapy, individual counseling, medication management, and psychoeducation. Our outcomes data show that Kolmac patients experience meaningful improvements in substance use, mental health, and overall well-being, with reduced relapse rates and higher retention than national averages.

Treating co-occurring mental health conditions

Many people who develop benzodiazepine dependence originally sought relief from anxiety, panic attacks, or insomnia.

At Kolmac, we understand that substance use rarely happens in isolation. Our integrated care model addresses co-occurring disorders, also known as dual diagnosis treatment, such as anxiety and depression, alongside addiction. This holistic approach improves outcomes and helps you build a foundation for lasting wellness.

What to expect when you start

Your journey begins with a confidential phone call to our admissions team, who will listen to your concerns and answer your questions.

You will then schedule a medical evaluation, where our clinicians assess your health, substance use, and mental health needs. If detox is appropriate, we will create a personalized plan and begin virtual supervision right away.

Most patients complete detox in five to ten days before transitioning to IOP, all while maintaining daily life commitments.

Frequently asked questions

Safe recovery starts with one call

If you or a loved one is struggling with benzodiazepine dependence, Kolmac’s medical team is ready to help quickly and safely. Our outpatient programs provide expert supervision, proven results, and compassionate support every step of the way.

Kolmac offers evidence-based treatment both virtually and in-person throughout Washington DC, Virginia, Maryland, and Pennsylvania.

Call: (888) 331-5251

Take your first step toward safe, lasting change. Contact Kolmac today and start your recovery journey.